Asarpota Rajesh 4

What Happened Asarpota Rajesh, Chief Financial Officer of Maravai LifeSciences (MRVI), had 65,584 shares withheld on 2026-06-30 to satisfy tax withholding obligations related to the vesting of restricted stock units (RSUs). The withholding was calculated at $6.39 per share, totaling approximately $419,082. This was a tax-withholding/net-share settlement, not an open-market sale.

Key Details

• Transaction date: 2026-06-30; Filing date: 2026-07-01 (timely Form 4).
• Type/code: F — shares withheld to satisfy tax withholding on vested RSUs.
• Shares withheld: 65,584 at $6.39 per share; total value ≈ $419,082.
• Footnote: F1 — confirms shares were withheld to satisfy tax withholding for RSU vesting.
• Shares owned after transaction: Not specified in the provided filing details.
• Filing timeliness: Report appears timely (filed the next day).

Context

• This is a routine tax-withholding transaction (net share settlement) tied to RSU vesting and does not represent an active decision to sell shares on the market. Such withholdings are common and typically do not signal insider sentiment.
• For retail investors: tax withholding transactions should be treated differently from discretionary insider purchases or sales — they reflect compensation mechanics rather than investment choices.